首页> 外文OA文献 >Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy

【2h】

Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy

机译：Regorafenib与氟嘧啶用于转移性结直肠癌的含量后多个5富含5富富福组合治疗和雄育单疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eric I. Marks; Carlyn Tan; Jun Zhang; Lanlan Zhou; Zhaohai Yang; Angelique Scicchitano; Wafik S. El-Deiry;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy [J] . Marks Eric I., Tan Carlyn, Zhang Jun, Cancer biology & therapy . 2015,第12期

机译：雷戈非尼联合氟嘧啶用于转移性结直肠癌的多种含5-FU联合疗法和雷戈非尼单药治疗后
2. Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy [J] . Angeles Arkhjamil, Hung Wayne, Cheung Winson Y. Medical oncology . 2018,第8期

机译：核心意向术术单疗法的核心难治性，K-RA野生型，转移结直肠癌的可靠性
3. Reduced Dose of Salvage-line Regorafenib Monotherapy for Metastatic Colorectal Cancer in Japan [J] . Hirano Gen, Makiyama Akitaka, Makiyama Chinatsu, Anticancer Research: International Journal of Cancer Research and Treatment . 2015,第1期

机译：在日本减少转移性雷戈非尼单药治疗转移性大肠癌的剂量
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. The evaluation of anti-cancer effects of FL118 in retinoblastoma in monotherapy and combination therapies. [D] . Singh, Jasman Kaur. 2014

机译：在单一疗法和联合疗法中评估FL118在视网膜母细胞瘤中的抗癌作用。
6. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy [O] . Eric I. Marks, Carlyn Tan, Jun Zhang, 2015

机译：雷戈非尼联合氟嘧啶用于转移性结直肠癌的多种含5-FU联合疗法和雷戈非尼单药治疗后进展
7. Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the CORRECT trial who had progression-free survival (PFS) longer than 4 months. [O] . Axel Grothey, Alfredo Falcone, Yves Humblet, 2015

机译：亚群分析患者患有术治疗（PFS）的Regorafenib（reg）治疗的转移性结直肠癌（incar）治疗的患者（ing），患者患者超过4个月。

Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅